Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
8 - Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
Published online by Cambridge University Press: 19 October 2021
Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Stahl's Self-Assessment Examination in PsychiatryMultiple Choice Questions for Clinicians, pp. 289 - 320Publisher: Cambridge University PressPrint publication year: 2019
References
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 12)1Google Scholar
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorder, fifth edition. Arlington, VA: American Psychiatric Publishing; 2013.1Google Scholar
References
Arnsten, AF. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 2006;67 (Suppl 8):7–12.1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 12)2Google Scholar
Stahl, SM, Mignon, L. Stahl’s illustrated attention deficit hyperactivity disorder. New York, NY: Cambridge University Press; 2009. (Chapter 1)3Google Scholar
References
Hoogman, M, Bralten, J, Hibar, DP et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry 2017;4(4):310–9.1Google ScholarPubMed
Shaw, P, Eckstrand, K, Sharp, W et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci 2007;104(49):19649–54.2Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 12)1Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 12)1Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 12)1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.2Google Scholar
References
Grady, MM, Stahl, SM. A horse of a different color: how formulation influences medication effects. CNS Spectr 2012;17:63–9.1Google Scholar
Neuroscience Education Institute. NEI Prescribe [Mobile application software]. 2017. Retrieved from http://nei.global/neiprescribeitunes.2Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013. (Chapter 12)1Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.2Google Scholar
References
Faraone, SV, Glatt, SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010;71(6):754–63.1Google Scholar
Faraone, SV, Biederman, J, Spencer, TJ, Aleardi, M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed 2006;8(4):4.2Google Scholar
Hanwella, R, Senanayake, M, de Silva, V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry 2011;11:176.3Google Scholar
References
Pietrzak, RH, Mollica, CM, Maruff, P, Snyder, PJ. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 2006;30:1225–45.1CrossRefGoogle ScholarPubMed
Swanson, J, Baler, MD, Volkow, ND. Understanding the effects of stimulant medications on cognition individuals with attention-defict hyperactivity disorder: a decade of progress. Neuropsychopharmacology 2011;36:207–26.2CrossRefGoogle Scholar
References
Den Heijer, AE, Groen, Y, Tucha, L et al. Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review. J Neural Transm (Vienna) 2017;124(Suppl 1):3–26.1CrossRefGoogle ScholarPubMed
Hoza, B, Martin, CP, Pirog, A, et al. Using physical activity to manage ADHD symptoms: The state of the evidence. Curr Psychiatry Rep 2016;18(12):113.2Google Scholar
References
McGough, JJ. Treatment controversies in adult ADHD. Am J Psychiatry 2016;173:960–6.1CrossRefGoogle ScholarPubMed
Wilens, TE, Morrison, NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry 2011;24:280–5.2Google Scholar
Wilens, TE, Morrison, NR, Prince, J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 2011;11(10):1443–65.3CrossRefGoogle ScholarPubMed
References
American Academy of Pediatrics/American Heart Association. American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD. J Dev Behav Pediatr 2008;29(4):335.1Google Scholar